Dr. Kai Joachimsen has been appointed as Chief Executive of the Federal Association of the Pharmaceutical Industry e. V. (BPI). He has been Deputy BPI General Manager since July 2018 and succeeds Henning Fahrenkamp, who retired at the end of 2018.
Regarding his appointment he has stated:
“More than ever, we need alliances for future-proof healthcare. We need to work with all stakeholders to create the right framework conditions for a competitive industry – and ultimately to put people’s medicine on safe footing. The BPI is a reliable partner for constructive exchange. “